PMC Articles for MedGen (Select 18014) - PMC

Result Filters

Links from MedGen

Items: 1 to 20 of 814

<< First< Prev

Page of 41

Select item 101951941.

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2

Justin T Jordan, Christina C Orr, Raquel D Thalheimer, Josephine V Cambillo, Roberta L Beauchamp, Ghalib Shaikh, Alona Muzikansky, Anat Stemmer-Rachamimov, Marco Giovannini, Michel Kalamarides, Fred G Barker, II, Vijaya Ramesh, Scott R Plotkin

Neurooncol Adv. 2023 Jan-Dec; 5(1): vdad041. Published online 2023 Apr 17. doi: 10.1093/noajnl/vdad041

PMCID:: PMC10195194

Article PDF–153K

Select item 98173792.

The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity

Anna Cecilia Lawson McLean, Anna Freier, Aaron Lawson McLean, Johannes Kruse, Steffen Rosahl

Orphanet J Rare Dis. 2023; 18: 3. Published online 2023 Jan 6. doi: 10.1186/s13023-022-02607-z

PMCID:: PMC9817379

Article PDF–2.0M

Select item 95791833.

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

Jineta Banerjee, Jan M. Friedman, Laura J. Klesse, Kaleb H. Yohay, Justin T. Jordan, Scott R. Plotkin, Robert J. Allaway, Jaishri O. Blakeley

Genet Med. 2023 Feb; 25(2): 100324. Published online 2022 Oct 19. doi: 10.1016/j.gim.2022.10.007

PMCID:: PMC9579183

Article PDF–882K

Select item 94507784.

Neurofibromatosis 2: hearing restoration options

Tatiana Alves Monteiro, Maria Valeria Schmidt Goffi-Gomez, Robinson Koji Tsuji, Marcos Queiroz Telas Gomes, Rubens Vuono Brito Neto, Ricardo Ferreira Bento

Braz J Otorhinolaryngol. 2012 Sep-Oct; 78(5): 128–134. Published online 2015 Nov 20. doi: 10.5935/1808-8694.20120020

PMCID:: PMC9450778

Article PDF–375K

Select item 93939355.

Reliability of functional outcome measures in adults with neurofibromatosis 2

Rebecca Louise Mullin, Rebecca Smith, Susan Wood, Angela Swampillai, Shazia Afridi

SAGE Open Med. 2022; 10: 20503121221118996. Published online 2022 Aug 19. doi: 10.1177/20503121221118996

PMCID:: PMC9393935

Article PDF–761K

Select item 93348286.

Erratum to “Neurofibromatosis 2: Rare constellation of findings with extensive cranial nerve involvement” [Radiology Case Reports 16 (2021) 157–165]

Rudresh Hiremath, Vishnu Dakshin, Sonal Agrawal

Radiol Case Rep. 2022 Sep; 17(9): 3454. Published online 2022 Jul 15. doi: 10.1016/j.radcr.2022.06.058

Corrects:: Radiol Case Rep. 2021 Jan; 16(1): 157–165.

PMCID:: PMC9334828

Correction PDF–196K

Select item 83646017.

Neurofibromatosis 2: Primary Modality of Hearing Rehabilitation with Cochlear Implant

Dathathri Anantaramaiah Halyur, Praveen H. Rayanagoudar, Apurva Kumar, Sunil Narayan Dutt

Indian J Otolaryngol Head Neck Surg. 2021 Sep; 73(3): 395–400. Published online 2021 Jun 15. doi: 10.1007/s12070-020-02321-x

PMCID:: PMC8364601

Article PDF–717K

Select item 78043598.

Optical coherence tomography significance in managing complex neurofibromatosis 2-related papilledema: Report of a case

Giacomo Maria Bacci, Flavio Giordano, Iacopo Sardi, Gareth Evans, Omar Pathmanaban, Carla Fonte, Franco Trabalzini, Sergio Nappini, Regina Mura, Roberto Caputo

JRSM Open. 2021 Jan; 12(1): 2054270420981454. Published online 2021 Jan 11. doi: 10.1177/2054270420981454

PMCID:: PMC7804359

Article PDF–569K

Select item 76741649.

Neurofibromatosis 2: rare constellation of findings with extensive cranial nerve involvement

Rudresh Hiremath, Vishnu Dakshin, Sonal Agrawal

Radiol Case Rep. 2021 Jan; 16(1): 157–165. Published online 2020 Nov 13. doi: 10.1016/j.radcr.2020.10.050

Correction in:: Radiol Case Rep. 2022 Sep; 17(9): 3454.

PMCID:: PMC7674164

Article PDF–2.8M

Select item 707793710.

Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment

Ontario Health (Quality)

Ont Health Technol Assess Ser. 2020; 20(4): 1–85. Published online 2020 Mar 6.

PMCID:: PMC7077937

Article PDF–1.1M

Select item 685866411.

Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)

Yu-chi Shen, Caroline Arellano-Garcia, Rosa E. Menjivar, Ethan M. Jewett, Wolfgang Dohle, Sofiia Karchugina, Jonathan Chernoff, Barry V. L. Potter, Kate F. Barald

BMC Pharmacol Toxicol. 2019; 20: 67. Published online 2019 Nov 15. doi: 10.1186/s40360-019-0369-8

PMCID:: PMC6858664

Article PDF–3.3M

Select item 659472312.

[¹⁸F]fluorothymidine and [¹⁸F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma

Jose M. Anton-Rodriguez, Daniel Lewis, Ibrahim Djoukhadar, David Russell, Peter Julyan, David Coope, Andrew T. King, Simon K. L. Lloyd, D. Gareth Evans, Alan Jackson, Julian C. Matthews

Otol Neurotol. 2019 Jul; 40(6): 826–835. Published online 2019 Apr 25. doi: 10.1097/MAO.0000000000002272

PMCID:: PMC6594723

Article PDF–1.5M

Select item 648842713.

From Process to Progress – 2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis

RE Ferner, A Bakker, Y Elgersma, DGR Evans, M Giovannini, E Legius, A Lloyd, LM Messiaen, S Plotkin, KM Reilly, A Schindeler, M Smith, NJ Ullrich, B Widemann, LS Sherman

Am J Med Genet A. Author manuscript; available in PMC 2020 Jun 1.

Published in final edited form as: Am J Med Genet A. 2019 Jun; 179(6): 1098–1106. Published online 2019 Mar 25. doi: 10.1002/ajmg.a.61112

PMCID:: PMC6488427

Article PDF–326K

Select item 633802014.

Relationships Between Neurofibromatosis-2, Progesterone Receptor Expression, the Use of Exogenous Progesterone, and Risk of Orbitocranial Meningioma in Females

Agus Supartoto, Muhammad Bayu Sasongko, Datu Respatika, Indra Tri Mahayana, Suhardjo Pawiroranu, Hari Kusnanto, Dhimas Hari Sakti, Prima Sugesty Nurlaila, Didik Setyo Heriyanto, Sofia Mubarika Haryana

Front Oncol. 2018; 8: 651. Published online 2019 Jan 9. doi: 10.3389/fonc.2018.00651

PMCID:: PMC6338020

Article PDF–394K

Select item 611448415.

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis

Vanessa L. Merker, Annie Dai, Heather B. Radtke, Pamela Knight, Justin T. Jordan, Scott R. Plotkin

BMC Health Serv Res. 2018; 18: 668. Published online 2018 Aug 29. doi: 10.1186/s12913-018-3471-5

PMCID:: PMC6114484

Article PDF–1.5M

Select item 592059716.

Low Incidence of a Nucleotide Sequence Alteration of the Neurofibromatosis 2 Gene in Human Breast Cancers

Sadanori Yaegashi, Richard Sachse, Noriaki Ohuchi, Shozo Mori, Takao Sekiya

Jpn J Cancer Res. 1995 Oct; 86(10): 929–933. doi: 10.1111/j.1349-7006.1995.tb03003.x

PMCID:: PMC5920597

Article PDF–514K

Select item 416568817.

Neurofibromatosis 2 Invasion of the Internal Auditory Canal Wall: Clinical Significance

Joni Doherty, John L. Go, Fred H. Linthicum, Jr.

Otol Neurotol. Author manuscript; available in PMC 2015 Oct 1.

Published in final edited form as: Otol Neurotol. 2014 Oct; 35(9): 1662–1668. doi: 10.1097/MAO.0000000000000494

PMCID:: PMC4165688

Article PDF–321K

Select item 403041318.

Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

Scott R. Plotkin, Chris Halpin, Michael J. McKenna, Jay S. Loeffler, Tracy T. Batchelor, Fred G. Barker, II

Otol Neurotol. Author manuscript; available in PMC 2014 May 22.

Published in final edited form as: Otol Neurotol. 2010 Sep; 31(7): 1135–1143. doi: 10.1097/MAO.0b013e3181eb328a

PMCID:: PMC4030413

Article PDF–2.5M

Select item 400878519.

Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2

Rosalie E. Ferner, Adam Shaw, D. Gareth Evans, Dympna McAleer, Dorothy Halliday, Allyson Parry, F. Lucy Raymond, Juliette Durie-Gair, C. Oliver Hanemann, Rachel Hornigold, Patrick Axon, John F. Golding

J Neurol. 2014; 261(5): 963–969. Published online 2014 Mar 12. doi: 10.1007/s00415-014-7303-1